Search results
Analysts Hunt for Undervalued Biotech Stocks
Digital Journal· 13 hours ago(NASDAQ: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. The Company's diversified pipeline includes ...
Vertex sues US over fertility support program for Casgevy gene editing therapy
Reuters via Yahoo Canada News· 2 days agoCasgevy is approved for the treatment of two genetic disorders - sickle cell disease and...
Vertex Suit Seeks US Permission to Pay for Fertility Treatments
Bloomberg· 2 days agoHave a confidential tip for our reporters? Vertex Pharmaceuticals Inc. sued the US government for...
Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and...
CNW· 3 days agoVertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Health Canada has granted Marketing Authorization for the expanded use of PrTRIKAFTA ...
Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus.com via Yahoo Finance Canada· 5 days agoFollowing this sale, the insider now owns 27,819 shares of Vertex Pharmaceuticals Inc. Vertex ...
Top Research Reports for Exxon Mobil, Merck & Qualcomm
Zacks via Yahoo Finance Canada· 5 days agoToday's Research Daily features new research reports on 16 major stocks, including Exxon Mobil...
Citius Pharmaceuticals Nears Key FDA Decisions and Launch Plans for 2024.
Digital Journal· 5 days ago"Our primary purpose and mission for these late-stage assets is to provide best-in-class, highly effective treatment options for patients and caregivers," Mazur added. "Ultimately, we believe ...
Biopharma Stocks Transformative Innovation for the Future of Health
Fairview Post· 7 days ago(NASDAQ: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. This advertisement has not loaded yet, but ...